Vitrolife AB (publ)

Equities

VITR

SE0011205202

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe Other stock markets 06:40:28 2023-11-29 am EST			5-day change	1st Jan Change
181.30 ^SEK	+5.41%		-0.27%	-2.52%

Nov. 24	Nordic Shares Moved Upward Friday; Marel Led Increases	DJ
Oct. 31	Nordic Stocks Rose Tuesday; NEL Led Increases	DJ

Vitrolife AB Announces Resignation of Maria Forss as Senior Vice President

August 23, 2023 at 08:30 am EDT

Vitrolife AB (publ) announced that Maria Forss, has resigned from her position as SVP Consumables business area in the company as she will assume the role of CEO BICO Group AB. Maria has been employed within the company since 2012 and has been leading the Consumables business area since 2017.

Latest news about Vitrolife AB (publ)

Nordic Shares Moved Upward Friday; Marel Led Increases	Nov. 24	DJ
Nordic Stocks Rose Tuesday; NEL Led Increases	Oct. 31	DJ
Nordic Stocks Closed Up Monday; Munters Group Topped Leaders	Oct. 30	DJ
Transcript : Vitrolife AB, Q3 2023 Earnings Call, Oct 27, 2023	Oct. 27	CI
Vitrolife AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Oct. 27	CI
Vitrolife AB Announces Election Committee Appointments	Oct. 05	CI
Nordic Stocks Declined Friday; H&M Hennes & Mauritz B Took Biggest Hit	Sep. 15	DJ
Vitrolife AB Announces Resignation of Maria Forss as Senior Vice President	Aug. 23	CI
BICO Group's President, CEO Resigns; Vitrolife Exec Named Successor	Aug. 22	MT
Vitrolife Japan Places Initial Order for Memphasys' Felix System	Aug. 13	MT
Memphasys Signs Exclusive Japan Distribution Deal for Reproductive Device; Shares Surge 23%	Aug. 06	MT
Nordic Shares Declined Wednesday; Kindred Group SDR Took Biggest Hit	Aug. 02	DJ
Nordic Shares Dropped Tuesday; Iceland Seafood International Posted Biggest Loss	Aug. 01	DJ
Vitrolife Chairman Steps Down; Successor Named	Aug. 01	MT
Vitrolife AB Announces Board Changes	Aug. 01	CI
Nordic Shares Dropped Friday; Vitrolife Fell Furthest	Jul. 28	DJ
Vitrolife AB (publ) : A pioneer in in vitro fertilization	Jul. 26
Transcript : Vitrolife AB, Q2 2023 Earnings Call, Jul 14, 2023	Jul. 14	CI
Vitrolife AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	Jul. 14	CI
Nordic Stocks Closed Down Wednesday; Engcon Cl B Took Biggest Hit	Jul. 05	DJ
Nordic Stocks Rose Friday; Autostore Holdings Climbed Highest	Jun. 16	DJ
An unknown buyer acquired a 3.7% stake in Vitrolife AB from EQT AB.	May. 15	CI
Yearly payment	Apr. 27	FA
Vitrolife AB Approves Dividend for the Financial Year 2022	Apr. 27	CI
Vitrolife AB Reports Earnings Results for the First Quarter Ended March 31, 2023	Apr. 21	CI

Chart Vitrolife AB (publ)

Duration

Period

More charts

Company Profile

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company's product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2023-12-11 - Capital Markets Day

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Vitrolife AB (publ) : A pioneer in in vitro fertilization

July 26, 2023 at 03:53 am EDT

More Strategies

Ratings for Vitrolife AB (publ)

Trading Rating :

Investor Rating :

ESG Refinitiv :

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

172.00SEK

Average target price

250.00SEK

Spread / Average Target

+45.35%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi. (M$)
VITROLIFE AB (PUBL)	-2.52%	2 251 M $
BIOMÉRIEUX	+1.14%	12 847 M $
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	+39.49%	7 690 M $
DIASORIN S.P.A.	-32.96%	4 986 M $
10X GENOMICS, INC.	+15.70%	4 984 M $
LANTHEUS HOLDINGS, INC.	+35.38%	4 725 M $
AUTOBIO DIAGNOSTICS CO., LTD.	-19.50%	4 048 M $
GUANGZHOU WONDFO BIOTECH CO.,LTD	-1.91%	1 934 M $
SHANGHAI RUNDA MEDICAL TECHNOLOGY CO., LTD.	+115.73%	1 769 M $
MYRIAD GENETICS, INC.	+28.74%	1 656 M $

Diagnostic & Testing Substances